Professional Documents
Culture Documents
Breast Lab-1
Breast Lab-1
Breast Lab-1
Figure 3. Anterior field showing MLC placement. The spinal cord (yellow) is completely
blocked and part of the esophagus (orange) is also blocked. My supraclav and axillary nodes
PTV opti (pink) was created to help me see my coverage.
Once satisfied with my anterior field, I created a posterior field with similar blocking and made
slight MLC adjustments on it. I went back and forth on whether to place this beam at 180
degrees or make truly opposed at 165 degrees. I went with the 165 degree angle due to the spinal
cord and esophagus being further out of the field and I didn’t notice much difference in coverage
otherwise.
I started with 6x energy for the anterior field due to how shallow the target was and wanting to
achieve good coverage near the skin and I used 18x energy for the posterior field since I was
trying to get dose further through the body. My coverage was not too bad from this, but my plan
was very hot at 130%. I then adjusted my anterior field to an 18x energy and this helped cool my
plan down to 119.5% while still getting good coverage on the anterior portion of my PTV.
Coverage
The dose coverage requirements for this lab were a little different than what the doctors at my
clinic site usually prefer. At my clinic site they commonly want 95% of the dose to cover 95%
percent of the volume for all the fields other than IM nodes which can go as low as 90% of the
dose covering 90% of the volume. There were two minimal coverage requirements for each
volume on this plan. The chest wall, supraclav, and axillary nodes were required to get a
minimum of 45 Gy covering 95% of the volume and 90% of the volume must be covered by 45
Gy. For the IM nodal volume, a minimum of 40 Gy must cover 95% of the volume and 80% of
the volume must be covered by 40 Gy.
My chest wall PTV had great coverage with 50.3 Gy covering 95% of the volume and 98.4% of
the volume being covered by 45 Gy. My IM nodes PTV was not as great but did meet the
requirements with 44.3 Gy covering 95% of the volume and 99.5% of the volume being covered
by 40 Gy. Figures 4, 5, and 6 show the isodose lines with the bold red line being a structure I
created that involved combining all my PTVs into one structure.
Constraints
As far as the metrics go for the Pro Know’s score card I was able to meet all the constraints.
There were 18 metrics given and I was able to get the “ideal” score on 7 of those, 7 of them I
achieved the “good” score, and I got the “acceptable” score on 4 of them. (My final scorecard
can be seen at the end of this assignment labeled as figure 18.) The constraint I struggled most
with was the heart. I initially did not have much of the heart covered by MLCs to allow my PTV
to be fully exposed to the beam, but I quickly found that I would not be able to meet the
constraint like that. I was unaware that you were able to cover the PTV in order to meet
constraints. After getting help from another dosimetrist, I closed the MLCs a bit more towards
the inferior portion of the chest wall PTV. This did decrease my coverage in that area, but
drastically improved my heart dose mean which felt like a fair tradeoff. This can be seen below
in figure 13.
Figure 13. BEV of medial tangent beam with target volumes and heart structure on.
I found my biggest mistake with this plan after I completed it, and I began to work on this write
up. My LAD mean dose was 2400 cGy. At my clinic site, our doctors prefer the LAD mean dose
to be around 700 cGy. It makes sense why the mean dose was so high since close to half of the
LAD is not blocked out on my tangent fields. I have not planned a left sided breast in clinic up to
this point so blocking it did not cross my mind. I now know from other plans I have done since
this one that it is crucial to block your LAD even if that means sacrificing PTV coverage. If I had
blocked more of the LAD, my coverage would have suffered in that location, but I believe I
would have been able to get my LAD mean dose down closer to 700 cGy. I did find a study
testing the correlation between certain LAD doses and major cardiac events. They found that
LAD doses over V15 Gy greater than or equal to 10% and a dose mean of 7 Gy increased
patients’ chances of a 2-year all-cause mortality estimate by nearly 10%.1 This estimate increases
if the patient has pre-existing heart issues. Keeping the LAD dose as low as possible is a very
important area to focus on during treatment planning. It is important to get proper coverage to
the target volumes for the patient, but it is equally as important to minimize harm to patients as
well.
Plan Sum Coverage
Below in figures 14, 15, and 16 show the isodose lines from my plan sum at isocenter in the
axial, frontal, and sagittal views.
ProKnow Scorecard
Figure 18. My ProKnow scorecard.
References
1. Atkins KM, Chaunzwa TL, Lamba N, et al. Association of Left Anterior Descending
Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients
With Non–Small Cell Lung Cancer. JAMAOncol. 2021;7(2):206-219.
doi:10.1001/jamaoncol.2020.6332